TNBC	Triple-Negative Breast Cancer
EMT	Epithelial–mesenchymal transition
CasIIIia	4,4′-dimethyl-2,2′-bipridine acetylacetonate copper(II) monohydrate nitrate
CasIIgly	4,7-dimethyl-1,10-phenanthroline glycinate copper(II) nitrate dihydrate
ATP	Adenosine triphosphate
NADPH	Nicotinamide adenine dinucleotide phosphate
HER2	Human epidermal growth factor receptor 2
BL1	Basal-like 1
BL2	Basal-like 2
M	Mesenchymal-like
LAR	Luminal androgen receptor
MDA-MB-231	Breast adenocarcinoma
TCA cycle	Citric acid cycle
GSH	Glutathione
FAO	Fatty acid oxidation
DNA	Deoxyribonucleic acid
ROS	Reactive oxygen species
HeLa	Human cervical adenocarcinoma
PI3K	Phosphatidylinositol-3-kinase
AKT	Protein kinase B
mTOR	Mammalian target of rapamycin
PI3K/AKT/mTOR pathway	Phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathway
1H-NMR	Proton nuclear magnetic resonance
ICP-MS	Inductively coupled plasma mass spectrometry
IC50	Half-maximal inhibitory concentration
SD	Standard deviation
PCA	Principal component analysis
PLS-DA	Partial least squares discriminant analysis
OPLS-DA	Orthogonal partial least squares discriminant analysis
VIP	Variable importance in projection
DMEM-F12	Dulbecco’s Modified Eagle Medium
MTT	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
TSP	Sodium 3-(trimethylsilyl)(2H4)propanoate
R2	Goodness of fit parameter
Q2	Variation predicted by a component
QEA	Quantitative enrichment analysis
PBS	Phosphate-Buffered Saline
HPS	High-Purity Standard